Ann: Incannex to Acquire APIRx Pharmaceuticals, page-71

The company is building out Therapies and its IP suite, this time it's in the CBDUniverse,

The Goal, of course, is that aspiration of building a business that could be comparable to that Market Cap of GW Pharma (AUD $9.9BLN - in the longer term)It is very much like a game of chess. It will not happen overnight and there are lots of little incremental moves that will be required to achieve it.

Like putting in place; a convenient way to raise Capital (NASDAQ), setting up a USA Office, appointing a PR agency, presenting our achievements at conferences, and so forth...If we were a resources company our growth would naturally follow taking over prospective plots of land and other mines with huge upside potential equally,

The path to quickly grow our Biotech Market Cap is to find a company with "a unique value proposition" with a suite of existing or pending Intellectual Property and Therapies that we can easily bolt on to our existing suite of Development pipelines.

With strong support from our existing IHL Long-Term Shareholder Base, a Share Issue to the old owners make this possible. In addition, we now have a tool to expand and develop, to raise capital to further develop any underdeveloped pipelines that may come our way via our Global Markets listing on the NASDAQ.

I have mentioned before that Incannex is a validated business with the Directors continuing to add skin into the game (approx 14%). More skin to come with the current oppies on offer. Adding and growing the company's Market Cap and developing its Business base/pipeline is the modus opera di of a Transformational Business like Incannex.

This is not a deal that just walked into the HQ door.
IHL has had a connection with Dr George E. Anastassov since 2018.
https://stocknessmonster.com/announcements/ihl.asx-3A501312/ We were distributors for them back then.

Up until July 2020, George E. Anastassov was CEO of AXIM, when his group of collaborators left AXIM. A formal separation agreement was filed. https://docoh.com/filing/1514946/0001078782-20-000562/AXIM-8K

Dr. Anastassov then became co-Founder and CEO of Netherlands-based APIRx. bringing with him all of his groups Patents - IP Filings from AXIM.

AXIM is now a shadow of its former self with an Mkt Cap of only $USD17.6M and a current SP of USD$0.13c a big contrast to Dr. Anastassov's leadership days when it had a market cap of up to US$1BN and an SP of up to USD$16 at its peak SP in 2017

" During his tenure as the President, CEO and Chairman of the Board he propelled the company from a market capitalization of $10 mln to over $1 bln. within a period of less than two years.

AXIM was named as one of the top 5 performing biotech stocks for 2016 by Fox Business News"
https://www.foxbusiness.com/markets/the-best-marijuana-stocks-in-2016

The company holds an extensive list of patents and trademarks https://apirxpharma.com/ip-portfolio/



https://cannaworldexpo.com/2020/02/10/dr-george-anastassov/?v=b0c4bc877c29


Soon to be subsidiary of Incannex ??



https://apirxpharma.com/

It appears on the face of it that, Joel (IHL) and Dr George have had known each other for a few years now and it's all coming together
THIS BIG STRATEGY OF BEING THE NEXT GW PHARMA IMO

GLAH